ZA913949B - Diagnosis and treatment of viral hepatitis - Google Patents

Diagnosis and treatment of viral hepatitis

Info

Publication number
ZA913949B
ZA913949B ZA913949A ZA913949A ZA913949B ZA 913949 B ZA913949 B ZA 913949B ZA 913949 A ZA913949 A ZA 913949A ZA 913949 A ZA913949 A ZA 913949A ZA 913949 B ZA913949 B ZA 913949B
Authority
ZA
South Africa
Prior art keywords
diagnosis
treatment
viral hepatitis
hepatitis
viral
Prior art date
Application number
ZA913949A
Other languages
English (en)
Inventor
William A Carter
A Carter William
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of ZA913949B publication Critical patent/ZA913949B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA913949A 1990-05-25 1991-05-24 Diagnosis and treatment of viral hepatitis ZA913949B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/528,962 US5132292A (en) 1990-05-25 1990-05-25 Treatment of viral hepatitis

Publications (1)

Publication Number Publication Date
ZA913949B true ZA913949B (en) 1992-06-24

Family

ID=24107946

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913949A ZA913949B (en) 1990-05-25 1991-05-24 Diagnosis and treatment of viral hepatitis

Country Status (13)

Country Link
US (1) US5132292A (xx)
EP (1) EP0531365A4 (xx)
JP (1) JP3208138B2 (xx)
CN (1) CN1059659A (xx)
AU (1) AU646050B2 (xx)
CA (1) CA2083603A1 (xx)
FI (1) FI925261A0 (xx)
HU (1) HUT65385A (xx)
IE (1) IE911782A1 (xx)
NZ (1) NZ238169A (xx)
PT (1) PT97749B (xx)
WO (1) WO1991018611A1 (xx)
ZA (1) ZA913949B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906980A (en) * 1987-07-17 1999-05-25 Hem Research Inc. Treatment of hepatitis with mismatched dsRNA
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US6521601B1 (en) * 1992-04-14 2003-02-18 Signal Pharmaceuticals, Inc. Method and composition for inhibition of viral replication
US5496546A (en) * 1993-02-24 1996-03-05 Jui H. Wang Compositions and methods of application of reactive antiviral polyadenylic acid derivatives
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome
GB0314824D0 (en) 2003-06-25 2003-07-30 Design Blue Ltd Energy absorbing material
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
US7943147B2 (en) * 2005-12-07 2011-05-17 Hemispherx Biopharma dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931397A (en) * 1971-11-05 1976-01-06 Beecham Group Limited Biologically active material
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape

Also Published As

Publication number Publication date
AU646050B2 (en) 1994-02-03
JP3208138B2 (ja) 2001-09-10
PT97749B (pt) 1998-10-30
EP0531365A1 (en) 1993-03-17
CN1059659A (zh) 1992-03-25
FI925261A (fi) 1992-11-19
US5132292A (en) 1992-07-21
AU7879691A (en) 1991-12-31
HUT65385A (en) 1994-06-28
EP0531365A4 (en) 1993-09-15
JPH05507481A (ja) 1993-10-28
PT97749A (pt) 1992-02-28
NZ238169A (en) 1997-07-27
CA2083603A1 (en) 1991-11-26
HU9203682D0 (en) 1993-04-28
WO1991018611A1 (en) 1991-12-12
FI925261A0 (fi) 1992-11-19
IE911782A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
EP0594677A4 (en) Antiviral liponucleosides: treatment of hepatitis b
ZA907564B (en) Treatment of conditions and disease
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
EP0531365A4 (en) Diagnosis and treatment of viral hepatitis
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
EP0506893A4 (en) Diagnosis and treatment of diseases
EP0557388A4 (en) Diagnosis and treatment of multiple sclerosis
IL105169A0 (en) Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv)
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
EP0472595A4 (en) Method of treatment of hepatitis
ZA914435B (en) Treatment of disease
NZ242876A (en) Stealth viruses and detection of associated diseases
EP0472663A4 (en) Method of treatment of hepatitis
BR9106503A (pt) Diagnostico e tratamento de hepatite viral
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
GB2250217B (en) Treatment of gas
GB9216360D0 (en) Treatment of blood
IL105387A0 (en) Treatment of hepatitis with gm-csf
IE880770L (en) Treatment of viral infections
PH27412A (en) Method of treatment of human immunodeficiency virus
BG98272A (en) Preparation and method for the treatment of virus hepatitis
EP0483086A3 (en) Process for the preparation of drugs for the treatment of hepatitis b, and drugs so obtained
IE892991L (en) Treatment of viral infections
NZ233973A (en) Treatment of viral and/or bacterial infections
NZ231322A (en) Treatment of viral and/or bacterial infections